Home / Repaglinide / Canada
CA ATC A10BX02 · updated 2 Nov 2026
Repaglinide shortage in Canada
Is there a Repaglinide shortage in Canada?
Yes. As of 2 Nov 2026, 3 Repaglinide products are reported short in Canada, the first since 1 Nov 2021. No return date has been given. Main reason: manufacturing problem.
Also short in Italy, Spain, Czechia, Sweden. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ACT REPAGLINIDE (100) | TEVA CANADA LIMITED | 1 Nov 2021 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACT REPAGLINIDE (100) | TEVA CANADA LIMITED | 1 Nov 2021 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACT REPAGLINIDE (100) | TEVA CANADA LIMITED | 16 Nov 2021 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.